Epoxidized Derivatives of Vigabatrin as a GABA-AT Inhibitor

References

1. Biochemical Pharmacology no.28 Metcalf, B. W.
2. Nature, Lond no.228 Krnjeric, K.
3. Lancet II Barbeau, A
4. Biochem. Pharmac. no.23 Roberts, E.
5. New Engl, J. Med. no.288 Perry, T. L.; Hansen, S.; Jkister, M. N.
6. J. Biochem. Pharmacol no.23 Karlesson, A.; Fonnum, F.; Malthe-Sorensen, D.; Storm-Mathisen, J.
7. Brain Res. no.8 Roberts, E.; Kuriyama, K.
8. J. Org. Chem. no.57 Kwon, T. W.; Keusenkothen, P. F.; Smith, M. B.
9. Arch. Neurol. no.44 Tassinari, C. A.; Michelucci, R.; Ambrosetto, G.; Salvi, F.
10. Br. J. Clin. Pharmacol. no.27 Browne, T. R.; Mattson, R. J.; Penry, J. K.; Smith, D. B.; Treiman, D. M.; Wilder, B. J.; Ben-Mensachem, E.; Miketta, R. M.; Sherry, K. M.; Szabo, G. K.
11. Chemistry and Enzymology v.1;2 Mechanism-Based Enzyme Inactivation Silverman, R. B.
12. Methods Enzymol. no.249 Silverman, R. B.
13. J. Chem. Soc., Perkin Trans no.1 Keusenkothen, P. F.; Smith, M. B.